Physical Medicine & Rehabilitation, Pain Medicine · Kissimmee, FL
NPI
1609304054
Since 2017
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1001 E Osceola Pkwy
Kissimmee, FL, 34744
Phone (321) 841-1570
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
2,266 services
Medicare patients, 2024
114
Average age 73
Drug cost, 2024
$111K
1,619 prescriptions
Company payments, 2025
$2,240
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rosa Zissimos was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,180 times for 20 patients. In total Rosa Zissimos billed 2,266 services in 45 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,180 | 20 | $0.10 | $122 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 258 | 18 | $0.09 | $23.34 |
| 99214 Office E&M - Established | Office | 130 | 71 | $90.10 | $12K |
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 60 | 30 | $0.29 | $17.21 |
| 99204 Office E&M - New | Office | 34 | 34 | $117.04 | $3,979 |
| 64493 Nerve Block Injection - Back | Office | 33 | 19 | $185.28 | $6,114 |
| 64494 Nerve Block Injection - Back | Office | 32 | 18 | $95.99 | $3,072 |
| 99215 Office E&M - Established | Office | 25 | 21 | $135.68 | $3,392 |
| 64483 Nerve Block Injection - Back | Office | 20 | 17 | $209.69 | $4,194 |
| 99213 Office E&M - Established | Office | 13 | 11 | $70.38 | $915 |
| 99205 Office E&M - New | Office | 13 | 13 | $110.70 | $1,439 |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 11 | 11 | $64.46 | $709 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 11 | 11 | $217.91 | $2,397 |
By year: 2022 $6,059 for 65 services; 2023 $53K for 663 services; 2024 $54K for 2,266 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rosa Zissimos prescribed most often to Medicare patients was Gabapentin, with 421 prescriptions and refills. In total Rosa Zissimos wrote 1,619 Medicare prescriptions that cost $111K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 421 | 503 | 125 | $3,971 |
| Diclofenac Sodium Generic | 142 | 157 | 59 | $13K |
| Pregabalin Generic | 124 | 141 | 35 | $2,098 |
| Methocarbamol Generic | 104 | 111 | 53 | $1,112 |
| Calcipotriene Generic | 96 | 108 | 21 | $31K |
| Piroxicam Generic | 93 | 93 | 24 | $50K |
| Cyclobenzaprine Hcl Generic | 92 | 101 | 56 | $723 |
| Baclofen Generic | 91 | 115 | 33 | $866 |
| Duloxetine Hcl Generic | 79 | 130 | 35 | $1,338 |
| Meloxicam Generic | 77 | 91 | 21 | $243 |
| Ibuprofen Generic | 49 | 49 | 22 | $337 |
| Diazepam Generic | 36 | 36 | 30 | $30.96 |
| Amitriptyline Hcl Generic | 29 | 29 | Under 11 | $107 |
| Tramadol Hcl Generic | 27 | 27 | 22 | $53.98 |
| Tizanidine Hcl Generic | 26 | 42 | 17 | $331 |
Brand drugs: - claims; generic drugs: 1,611 claims; opioid claims: 38.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rosa Zissimos $2,240 ($1,175 in general payments such as food, travel and fees and $1,065 for research) from 12 companies. The largest payer was Boehringer Ingelheim International GmbH with $1,065.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim International GmbH | 3 | $1,065 |
| Abbvie Inc. ABBV | 8 | $226 |
| Medtronic, Inc. MDT | 7 | $216 |
| Stryker Corporation SYK | 1 | $164 |
| MML US, Inc. | 1 | $109 |
| Boston Scientific Corporation BSX | 3 | $108 |
| Globus Medical, Inc. GMED | 4 | $88.52 |
| Vertex Pharmaceuticals Incorporated VRTX | 3 | $81.02 |
| OsteoCentric Technologies, Inc. | 1 | $69.77 |
| Abbott Laboratories ABT | 2 | $48.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.